---
document_datetime: 2025-12-29 09:49:56
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/silodyx.html
document_name: silodyx.html
version: success
processing_time: 0.1277653
conversion_datetime: 2025-12-30 02:30:14.923018
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Silodyx

[RSS](/en/individual-human-medicine.xml/66365)

##### Authorised

This medicine is authorised for use in the European Union

silodosin Medicine Human Authorised

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [Topics](#topics)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

This is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the studies performed, to reach its recommendations on how to use the medicine.

If you need more information about your medical condition or your treatment, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist. If you want more information on the basis for the CHMP recommendations, read the scientific discussion (also part of the EPAR).

Expand section

Collapse section

## What is Silodyx?

Silodyx is a medicine that contains the active substance silodosin. It is available as capsules (4 and 8 mg).

## What is Silodyx used for?

Silodyx is used to treat the symptoms of benign prostatic hyperplasia (BPH, an enlarged prostate gland) in adults. The prostate gland is an organ found at the base of the bladder in men. When enlarged, it can cause problems with the flow of urine.

The medicine can only be obtained with a prescription.

## How is Silodyx used?

The recommended dose is one 8-mg capsule once a day. For men with moderate kidney problems, the starting dose should be 4 mg once a day. This may be increased to 8 mg once a day after a week.

Silodyx is not recommended for patients with severe kidney problems.

The capsules should be taken with food, preferably at the same time every day. They should be swallowed whole, preferably with a glass of water.

## How does Silodyx work?

The active substance in Silodyx, silodosin, is an alpha-adrenoreceptor antagonist. It works by blocking receptors called alpha1A adrenoreceptors in the prostate gland, the bladder and the urethra (the tube that leads from the bladder to the outside of the body). When these receptors are activated, they cause the muscles controlling the flow of urine to contract. By blocking these receptors, silodosin allows these muscles to relax, making it easier to pass urine and relieving the symptoms of BPH.

## How has Silodyx been studied?

The effects of Silodyx were first tested in experimental models before being studied in humans.

Silodyx has been compared with placebo (a dummy treatment) in three main studies involving over 1,800 men with BPH. One of these studies also compared Silodyx with tamsulosin (another medicine used for BPH).

The main measure of effectiveness in all three studies was the improvement of the patients' international prostate symptom score (IPSS) after 12 weeks of treatment. IPSS is a rating of the patient's symptoms such as the inability to empty the bladder, and the urge to urinate repeatedly or to strain while urinating. The patients rated the severity of their symptoms themselves.

## What benefit has Silodyx shown during the studies?

Silodyx was more effective than placebo and as effective as tamsulosin at reducing symptoms of BPH.

In the two studies where Silodyx was compared only with placebo, the IPSS was around 21 points at the start of the study. After 12 weeks, it had fallen by around 6.4 points in the men who took Silodyx, and by around 3.5 points in the men who took placebo. In the third study, IPSS was around 19 points before treatment, falling by 7.0 points in the men who took Silodyx after 12 weeks, 6.7 points in the men who took tamsulosin and 4.7 points in the men who took placebo.

## What is the risk associated with Silodyx?

The most common side effect with Silodyx (seen in more than 1 patient in 10) is a reduction in the amount of semen released during ejaculation. Intra operative floppy iris syndrome (IFIS) occurs in some patients taking alpha adrenoreceptor antagonists and may lead to complications during cataract surgery. IFIS is a condition that makes the iris floppy.

For the full list of all side effects and restrictions with Silodyx, see the package leaflet.

## Why has Silodyx been approved?

The CHMP decided that Silodyx's benefits are greater than its risks and recommended that it be given marketing authorisation.

## What measures are being taken to ensure the safe and effective use of Silodyx?

The company that makes Silodyx will ensure that eye surgeons are provided with information on IFIS in all Member States where the medicine will be marketed.

A risk management plan has been developed to ensure that Silodyx is used as safely as possible. Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Silodyx, including the appropriate precautions to be followed by healthcare professionals and patients.

In addition, the company that makes Silodyx will ensure that eye surgeons are provided with information on IFIS in all Member States where the medicine will be marketed.

## Other information about Silodyx

The European Commission granted a marketing authorisation valid throughout the European Union for Silodyx on 29 January 2010.

For more information about treatment with Silodyx, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.

Silodyx : EPAR - Summary for the public

English (EN) (73.8 KB - PDF)

**First published:** 22/02/2010

**Last updated:** 09/10/2014

[View](/en/documents/overview/silodyx-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-695)

български (BG) (102.98 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

09/10/2014

[View](/bg/documents/overview/silodyx-epar-summary-public_bg.pdf)

español (ES) (74.82 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

09/10/2014

[View](/es/documents/overview/silodyx-epar-summary-public_es.pdf)

čeština (CS) (124.18 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

09/10/2014

[View](/cs/documents/overview/silodyx-epar-summary-public_cs.pdf)

dansk (DA) (81.43 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

09/10/2014

[View](/da/documents/overview/silodyx-epar-summary-public_da.pdf)

Deutsch (DE) (76.06 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

09/10/2014

[View](/de/documents/overview/silodyx-epar-summary-public_de.pdf)

eesti keel (ET) (73.74 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

09/10/2014

[View](/et/documents/overview/silodyx-epar-summary-public_et.pdf)

ελληνικά (EL) (100.59 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

09/10/2014

[View](/el/documents/overview/silodyx-epar-summary-public_el.pdf)

français (FR) (76.17 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

09/10/2014

[View](/fr/documents/overview/silodyx-epar-summary-public_fr.pdf)

hrvatski (HR) (96.24 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

09/10/2014

[View](/hr/documents/overview/silodyx-epar-summary-public_hr.pdf)

italiano (IT) (73.71 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

09/10/2014

[View](/it/documents/overview/silodyx-epar-summary-public_it.pdf)

latviešu valoda (LV) (96.79 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

09/10/2014

[View](/lv/documents/overview/silodyx-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (98.81 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

09/10/2014

[View](/lt/documents/overview/silodyx-epar-summary-public_lt.pdf)

magyar (HU) (95.61 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

09/10/2014

[View](/hu/documents/overview/silodyx-epar-summary-public_hu.pdf)

Malti (MT) (102.25 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

09/10/2014

[View](/mt/documents/overview/silodyx-epar-summary-public_mt.pdf)

Nederlands (NL) (75.4 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

09/10/2014

[View](/nl/documents/overview/silodyx-epar-summary-public_nl.pdf)

polski (PL) (102.29 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

09/10/2014

[View](/pl/documents/overview/silodyx-epar-summary-public_pl.pdf)

português (PT) (75.8 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

09/10/2014

[View](/pt/documents/overview/silodyx-epar-summary-public_pt.pdf)

română (RO) (97.46 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

09/10/2014

[View](/ro/documents/overview/silodyx-epar-summary-public_ro.pdf)

slovenčina (SK) (99.78 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

09/10/2014

[View](/sk/documents/overview/silodyx-epar-summary-public_sk.pdf)

slovenščina (SL) (96.05 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

09/10/2014

[View](/sl/documents/overview/silodyx-epar-summary-public_sl.pdf)

Suomi (FI) (74.05 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

09/10/2014

[View](/fi/documents/overview/silodyx-epar-summary-public_fi.pdf)

svenska (SV) (74.47 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

09/10/2014

[View](/sv/documents/overview/silodyx-epar-summary-public_sv.pdf)

## Product information

Silodyx : EPAR - Product information

English (EN) (390.14 KB - PDF)

**First published:** 22/02/2010

**Last updated:** 14/03/2025

[View](/en/documents/product-information/silodyx-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-461)

български (BG) (459.87 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/bg/documents/product-information/silodyx-epar-product-information_bg.pdf)

español (ES) (388.45 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/es/documents/product-information/silodyx-epar-product-information_es.pdf)

čeština (CS) (448.77 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/cs/documents/product-information/silodyx-epar-product-information_cs.pdf)

dansk (DA) (392.62 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/da/documents/product-information/silodyx-epar-product-information_da.pdf)

Deutsch (DE) (402.5 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/de/documents/product-information/silodyx-epar-product-information_de.pdf)

eesti keel (ET) (401.79 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/et/documents/product-information/silodyx-epar-product-information_et.pdf)

ελληνικά (EL) (471.47 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/el/documents/product-information/silodyx-epar-product-information_el.pdf)

français (FR) (394.78 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/fr/documents/product-information/silodyx-epar-product-information_fr.pdf)

hrvatski (HR) (437.92 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/hr/documents/product-information/silodyx-epar-product-information_hr.pdf)

íslenska (IS) (386.39 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/is/documents/product-information/silodyx-epar-product-information_is.pdf)

italiano (IT) (389.77 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/it/documents/product-information/silodyx-epar-product-information_it.pdf)

latviešu valoda (LV) (457.77 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/lv/documents/product-information/silodyx-epar-product-information_lv.pdf)

lietuvių kalba (LT) (452.12 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/lt/documents/product-information/silodyx-epar-product-information_lt.pdf)

magyar (HU) (451.37 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/hu/documents/product-information/silodyx-epar-product-information_hu.pdf)

Malti (MT) (499.87 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/mt/documents/product-information/silodyx-epar-product-information_mt.pdf)

Nederlands (NL) (400.5 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/nl/documents/product-information/silodyx-epar-product-information_nl.pdf)

norsk (NO) (391.58 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/no/documents/product-information/silodyx-epar-product-information_no.pdf)

polski (PL) (459.95 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/pl/documents/product-information/silodyx-epar-product-information_pl.pdf)

português (PT) (391.7 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/pt/documents/product-information/silodyx-epar-product-information_pt.pdf)

română (RO) (459.6 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/ro/documents/product-information/silodyx-epar-product-information_ro.pdf)

slovenčina (SK) (505.88 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/sk/documents/product-information/silodyx-epar-product-information_sk.pdf)

slovenščina (SL) (447.37 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/sl/documents/product-information/silodyx-epar-product-information_sl.pdf)

Suomi (FI) (390.09 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/fi/documents/product-information/silodyx-epar-product-information_fi.pdf)

svenska (SV) (371.26 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

14/03/2025

[View](/sv/documents/product-information/silodyx-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** N/0000255291 10/02/2025

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Silodyx : EPAR - All Authorised presentations

English (EN) (34.29 KB - PDF)

**First published:** 22/02/2010

**Last updated:** 10/10/2022

[View](/en/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-834)

български (BG) (67.58 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/bg/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_bg.pdf)

español (ES) (34.7 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/es/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_es.pdf)

čeština (CS) (56.16 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/cs/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (35.21 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/da/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (33.57 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/de/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (35.23 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/et/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (58.22 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/el/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_el.pdf)

français (FR) (35.33 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/fr/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (48.76 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/hr/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (33 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/is/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_is.pdf)

italiano (IT) (30.71 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/it/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (56.1 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/lv/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (56.38 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/lt/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (52.83 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/hu/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (48.33 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/mt/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (33.37 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/nl/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (34.91 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/no/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_no.pdf)

polski (PL) (54.72 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/pl/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_pl.pdf)

português (PT) (32.12 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/pt/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_pt.pdf)

română (RO) (56.19 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/ro/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (50.97 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/sk/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (40.58 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/sl/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (36.23 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/fi/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (34.96 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

10/10/2022

[View](/sv/documents/all-authorised-presentations/silodyx-epar-all-authorised-presentations_sv.pdf)

Silodyx : EPAR - Conditions imposed on member states for safe and effective use - Annex IV

English (EN) (83.75 KB - PDF)

**First published:** 22/02/2010

**Last updated:** 22/02/2010

[View](/en/documents/conditions-member-states/silodyx-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_en.pdf)

[Other languages (21)](#file-language-dropdown-761)

български (BG) (158.14 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/bg/documents/conditions-member-states/silodyx-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_bg.pdf)

español (ES) (74.7 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/es/documents/conditions-member-states/silodyx-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_es.pdf)

čeština (CS) (102.34 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/cs/documents/conditions-member-states/silodyx-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_cs.pdf)

dansk (DA) (68.08 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/da/documents/conditions-member-states/silodyx-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_da.pdf)

Deutsch (DE) (78.04 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/de/documents/conditions-member-states/silodyx-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_de.pdf)

eesti keel (ET) (68.58 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/et/documents/conditions-member-states/silodyx-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_et.pdf)

ελληνικά (EL) (154.82 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/el/documents/conditions-member-states/silodyx-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_el.pdf)

français (FR) (80.37 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/fr/documents/conditions-member-states/silodyx-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_fr.pdf)

italiano (IT) (71.26 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/it/documents/conditions-member-states/silodyx-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_it.pdf)

latviešu valoda (LV) (106.36 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/lv/documents/conditions-member-states/silodyx-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_lv.pdf)

lietuvių kalba (LT) (102.11 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/lt/documents/conditions-member-states/silodyx-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_lt.pdf)

magyar (HU) (77.08 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/hu/documents/conditions-member-states/silodyx-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_hu.pdf)

Malti (MT) (114.92 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/mt/documents/conditions-member-states/silodyx-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_mt.pdf)

Nederlands (NL) (78.65 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/nl/documents/conditions-member-states/silodyx-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_nl.pdf)

polski (PL) (104.06 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/pl/documents/conditions-member-states/silodyx-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_pl.pdf)

português (PT) (72.67 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/pt/documents/conditions-member-states/silodyx-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_pt.pdf)

română (RO) (102.52 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/ro/documents/conditions-member-states/silodyx-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_ro.pdf)

slovenčina (SK) (156.55 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/sk/documents/conditions-member-states/silodyx-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_sk.pdf)

slovenščina (SL) (91.79 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/sl/documents/conditions-member-states/silodyx-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_sl.pdf)

Suomi (FI) (74.44 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/fi/documents/conditions-member-states/silodyx-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_fi.pdf)

svenska (SV) (72.74 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/sv/documents/conditions-member-states/silodyx-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_sv.pdf)

## Product details

Name of medicine Silodyx Active substance silodosin International non-proprietary name (INN) or common name silodosin Therapeutic area (MeSH) Prostatic Hyperplasia Anatomical therapeutic chemical (ATC) code G04CA04

### Pharmacotherapeutic group

Urologicals

### Therapeutic indication

Treatment of the signs and symptoms of benign prostatic hyperplasia (BPH)

## Authorisation details

EMA product number EMEA/H/C/001209 Marketing authorisation holder

Recordati Ireland Ltd

Raheens East

Marketing authorisation issued 29/01/2010 Revision 17

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Silodyx : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (140.55 KB - PDF)

**First published:** 15/06/2010

**Last updated:** 14/03/2025

[View](/en/documents/procedural-steps-after/silodyx-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf)

Silodyx-H-C-1209-PSUV-0013 : EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Adopted

Reference Number: EMA/719950/2013

English (EN) (69.7 KB - PDF)

**First published:** 25/11/2013

**Last updated:** 25/11/2013

[View](/en/documents/scientific-conclusion/silodyx-h-c-1209-psuv-0013-epar-scientific-conclusions-and-grounds-recommending-variation-terms-marketing-authorisation_en.pdf)

## Initial marketing authorisation documents

Silodyx : EPAR - Public assessment report

English (EN) (619.68 KB - PDF)

**First published:** 22/02/2010

**Last updated:** 22/02/2010

[View](/en/documents/assessment-report/silodyx-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Silodyx

Adopted

Reference Number: EMEA/CHMP/752757/2009

English (EN) (74.63 KB - PDF)

**First published:** 19/11/2009

**Last updated:** 19/11/2009

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-silodyx_en.pdf)

#### Topics

- [Medicines](https://www.ema.europa.eu/en/search?f%5B0%5D=ema_search_topics%3A61)

**This page was last updated on** 14/03/2025

## Share this page

[Back to top](#main-content)